2026, No. 01
Published on:January 5, 2026
¥ 0 ¥ 0
Efficacy of novel therapies for refractory and relapsed multiple myeloma in Chinafree
2026,139(1):1-3 DOI: 10.1097/CM9.0000000000003832
Platinum-resistant ovarian cancer in China: Practice and challengesfree
2026,139(1):4-6 DOI: 10.1097/CM9.0000000000003763
Clostridioides difficile: A suspected pro-carcinogenic bacterium for gastrointestinal tumorsfree
2026,139(1):7-22 DOI: 10.1097/CM9.0000000000003834
Role of LINE-1 in the nervous system and neurological disordersfree
2026,139(1):23-33 DOI: 10.1097/CM9.0000000000003891
Data-driven spatial-temporal framework for exploring the heterogeneity and temporality of sepsisfree
2026,139(1):34-47 DOI: 10.1097/CM9.0000000000003849
2026,139(1):48-57 DOI: 10.1097/CM9.0000000000003898
Association between family history and onset age of cancer in Chinafree
2026,139(1):58-64 DOI: 10.1097/CM9.0000000000003624
2026,139(1):65-82 DOI: 10.1097/CM9.0000000000003605
2026,139(1):83-92 DOI: 10.1097/CM9.0000000000003422
2026,139(1):93-107 DOI: 10.1097/CM9.0000000000003788
Development and validation of deep learning for predicting the growth of ovarian cancer organoidsfree
2026,139(1):108-117 DOI: 10.1097/CM9.0000000000003575
2026,139(1):118-135 DOI: 10.1097/CM9.0000000000003603
2026,139(1):136-138 DOI: 10.1097/CM9.0000000000003858
2026,139(1):139-141 DOI: 10.1097/CM9.0000000000003885
2026,139(1):142-144 DOI: 10.1097/CM9.0000000000003836
2026,139(1):145-147 DOI: 10.1097/CM9.0000000000003879
Targeting XPO1: A new perspective for malignant solid tumor especially small cell lung cancerfree
2026,139(1):148-150 DOI: 10.1097/CM9.0000000000003654
2026,139(1):151-153 DOI: 10.1097/CM9.0000000000003678
2026,139(1):154-154 DOI: 10.1097/cma.j.issn.0366-6999.2026.01.101
2026,139(1):154-154 DOI: 10.1097/cma.j.issn.0366-6999.2026.01.102
刊 期:中华医学杂志(英文版)2026年139卷01期
会员价:20元 原价:10 元
账户余额:20 元